GlassScriptPhysician profile
Benjamin H Holland
NPI 1871715482
$8,337.14
in general payments reported to CMS, 2019-2025
29 companies · $1,492 in 2025
The $1,492 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $728 · 2021: $889 · 2022: $1,400 · 2023: $1,742 · 2024: $1,649 · 2025: $1,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,883.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,128.39 | 2019-2025 | Aveir, Navitor, Amplatzer Amulet |
| Cardiva Medical, INC. | $937.94 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Edwards Lifesciences Corporation | $783.45 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Novartis Pharmaceuticals Corporation | $703.31 | 2019-2025 | |
| Boston Scientific Corporation | $605.65 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $480.29 | 2020-2025 | Lifevest |
| Amgen INC. | $410.73 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $397.82 | 2019-2025 | Farxiga, Wainua |
| Abiomed | $276.77 | 2021-2025 | Impella |
| Janssen Pharmaceuticals, INC | $227.18 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $221.85 | 2021-2023 | Angiovac |
| E.R. Squibb & Sons, L.L.C. | $219.16 | 2019-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $181.05 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Recor Medical INC | $164.69 | 2025 | Paradise Ultrasound Renal Denervation System |
| Chiesi USA, INC. | $110.68 | 2019-2025 | Kengreal |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $79.17 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $69.85 | 2021-2024 | Verquvo |
| Irhythm Technologies, INC. | $65.82 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Cardiovascular Systems INC. | $44.62 | 2020-2023 | Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.13 | 2021 | |
| Medtronic Vascular, INC. | $30.58 | 2020 | |
| Amarin Pharma, INC. | $29.49 | 2019 | |
| Alnylam Pharmaceuticals INC. | $28.81 | 2024 | Amvuttra |
| Novo Nordisk INC | $19.42 | 2021 | |
| Cordis US Corp. | $18.81 | 2024 | Mynx Control |
| Sanofi-Aventis U.S. LLC | $18.40 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.39 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $17.98 | 2023 | Uptravi, Opsumit |
| Cvrx, INC. | $14.71 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.